Examples
| Brand Name | Chemical Name |
| Apresazide [contains a diuretic], Apresoline | hydralazine hydrochloride |
| Lotensin | benazepril |
| Capoten | captopril |
| Vasotec | enalapril |
| Monopril | fosinopril |
| Prinivil, Zestril | lisinopril |
| Accupril | quinapril |
| Altace | ramipril |
| Mavik | trandolapril |
| Nipride, Nitropress | nitroprusside (used in acute MR) |
Angiotensin-converting enzyme (ACE) inhibitors:
| Brand Name | Chemical Name |
| Apresazide [contains a diuretic], Apresoline | hydralazine hydrochloride |
| Lotensin | benazepril |
| Capoten | captopril |
| Vasotec | enalapril |
| Monopril | fosinopril |
| Prinivil, Zestril | lisinopril |
| Accupril | quinapril |
| Altace | ramipril |
| Mavik | trandolapril |
| Nipride, Nitropress | nitroprusside (used in acute MR) |
Nitrates:
| Brand Name | Chemical Name |
| Apresazide [contains a diuretic], Apresoline | hydralazine hydrochloride |
| Lotensin | benazepril |
| Capoten | captopril |
| Vasotec | enalapril |
| Monopril | fosinopril |
| Prinivil, Zestril | lisinopril |
| Accupril | quinapril |
| Altace | ramipril |
| Mavik | trandolapril |
| Nipride, Nitropress | nitroprusside (used in acute MR) |
How It Works
Vasodilators work on different substances in the body to help widen (dilate) blood vessels.
Why It Is Used
Vasodilators are used for mitral valve regurgitation (MR) because the wider blood vessel will reduce resistance in blood flow and make it easier for blood to move forward from the left atrium to the left ventricle to the aorta. This helps reduce the amount of blood that leaks backward through the valve into the left atrium.
How Well It Works
Data support the use of vasodilators in those with acute and chronic MR when the left ventricle is enlarged. However, there are no data to support using vasodilators in mitral valve regurgitation with no symptoms or with normal ventricular function.1
Side Effects
Hydralazine may lower blood pressure, which may cause symptoms of dizziness, weakness, fainting, or fluid retention. People whose blood pressure is low when they start therapy will generally be started with a low dose and may need close monitoring to avoid reducing blood pressure too much. Hydralazine may also result in an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); numbness, tingling, pain, or weakness of arms or legs; irregular or very fast heartbeat; new or worsening chest pain; or fainting.
ACE inhibitors may cause a dry cough, allergy symptoms, rash or itching, allergic reaction with generalized swelling (angioedema), and excess potassium in the body (hyperkalemia), especially in people with kidney failure.
ACE inhibitors may interact with nonsteroidal anti-inflammatory drugs (NSAIDs), antacids, potassium supplements, certain diuretics, and lithium.
Nitroprusside may cause severe low blood pressure leading to death. Using too much too quickly may result in cyanide levels that the body cannot dispose of, leading to cyanide poisoning. Nitroprusside is generally only used in acute mitral regurgitation in patients who are hospitalized.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
Nitroprusside should not be used in acute MR if the person with MR already has low blood pressure, because this medication may further decrease blood pressure.
ACE inhibitors must be used carefully in people with severe kidney failure caused by diabetic nephropathy. A low dose is tried first. Potassium levels and kidney function are watched closely as the dose is increased.
Although vasodilators are used in acute MR, the benefits of using them for chronic MR are less clear.2
Complete the new medication information form (PDF)
(What is a PDF document?) to help you understand this medication.
References
Citations
Otto CM (2001). Evaluation and management of chronic mitral regurgitation. New England Journal of Medicine, 345(10): 740–746.
Bonow RO, Braunwald E (2004). Valvular heart disease. In DP Zipes et al,. eds., Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., pp. 1553–1632. Philadelphia: Elsevier Saunders.
Credits
| Author | Kathe Gallagher, MSW |
| Author | Cynthia Tank |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman |
| Associate Editor | Terrina Vail |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Primary Medical Reviewer | Kathleen Romito, MD - Family Medicine |
| Specialist Medical Reviewer | Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology |
| Last Updated | April 3, 2006 |
Cynthia Tank
© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.

